These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. LncRNA Li Z; Li M; Xia P; Wang L; Lu Z Cancer Manag Res; 2021; 13():9037-9048. PubMed ID: 34916848 [TBL] [Abstract][Full Text] [Related]
3. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis. Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603 [TBL] [Abstract][Full Text] [Related]
4. LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis. Zeng Z; Zhao G; Zhu H; Nie L; He L; Liu J; Li R; Xiao S; Hua G Cancer Cell Int; 2020; 20():350. PubMed ID: 32742197 [TBL] [Abstract][Full Text] [Related]
5. Wan N; Yang W; Cheng H; Wang J Cancer Biother Radiopharm; 2020 Oct; 35(8):596-604. PubMed ID: 32354225 [No Abstract] [Full Text] [Related]
6. Long non-coding RNA LINC00346 regulates proliferation and apoptosis by targeting miR-128-3p/SZRD1 axis in glioma. Geng YB; Pan CC; Xu C; Zuo PC; Wang Y; Li XO; Zhang LW Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9581-9590. PubMed ID: 33015801 [TBL] [Abstract][Full Text] [Related]
7. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2. Chen X; Gao J; Yu Y; Zhao Z; Pan Y Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886 [TBL] [Abstract][Full Text] [Related]
8. LncRNA ASB16-AS1 Promotes Growth and Invasion of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis and Activating Wnt/β-Catenin Pathway [Retraction]. Cancer Manag Res; 2022; 14():501-502. PubMed ID: 35177934 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway. Chen Y; Gao H; Li Y Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422 [TBL] [Abstract][Full Text] [Related]
11. SP1-induced lncRNA FOXD3-AS1 contributes to tumorigenesis of cervical cancer by modulating the miR-296-5p/HMGA1 pathway. Ma WG; Shi SM; Chen L; Lou G; Feng XL J Cell Biochem; 2021 Feb; 122(2):235-248. PubMed ID: 32959937 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p. Wu Q; Shi M; Meng W; Wang Y; Hui P; Ma J J Cell Physiol; 2019 Dec; 234(12):21889-21902. PubMed ID: 31058315 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA UBE2R2-AS1 promotes glioma cell apoptosis via targeting the miR-877-3p/TLR4 axis. Xu W; Hu GQ; Da Costa C; Tang JH; Li QR; Du L; Pan YW; Lv SQ Onco Targets Ther; 2019; 12():3467-3480. PubMed ID: 31123407 [No Abstract] [Full Text] [Related]
14. LncRNA MCM3AP-AS1 Promotes Cell Proliferation and Invasion Through Regulating miR-543-3p/SLC39A10/PTEN Axis in Prostate Cancer [Retraction]. Onco Targets Ther; 2023; 16():579-580. PubMed ID: 37465588 [TBL] [Abstract][Full Text] [Related]
15. LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis [Retraction]. Cancer Manag Res; 2023; 15():979-980. PubMed ID: 37693223 [TBL] [Abstract][Full Text] [Related]
16. Retraction: LncRNA ZEB2-AS1 regulates the drug resistance of acute myeloid leukemia Fisher L RSC Adv; 2021 Jan; 11(10):5762. PubMed ID: 35427052 [TBL] [Abstract][Full Text] [Related]
17. lncRNA FOXD3-AS1 promotes the progression of non-small cell lung cancer by regulating the miR-135a-5p/CDK6 axis. Guo H; Lin S; Gan Z; Xie J; Zhou J; Hu M Oncol Lett; 2021 Dec; 22(6):853. PubMed ID: 34733371 [TBL] [Abstract][Full Text] [Related]